Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Diarrhea chronic)
10,865 results
  • Business travel-associated illness: a GeoSentinel analysis. [Journal Article]
  • JTJ Travel Med 2018 Jan 01; 25(1)
  • Chen LH, Leder K, … GeoSentinel Surveillance Network
  • CONCLUSIONS: Diarrheal illness was a major cause of morbidity. Malaria contributed substantial morbidity and mortality, particularly among business travelers to sub-Saharan Africa. Underuse or non-use of chemoprophylaxis contributed to malaria cases. Deaths in business travelers could be reduced by improving adherence to malaria chemoprophylaxis and targeted vaccination for vaccine-preventable diseases. Pre-travel advice is indicated for business travelers and is currently under-utilized and needs improvement.
  • Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL. [Journal Article]
  • JDJ Drugs Dermatol 2018 Feb 01; 17(2):221-228
  • Stein Gold L, Bagel J, … Duffin KC
  • CONCLUSIONS: Apremilast was effective in systemic-naive patients with moderate plaque psoriasis with BSA 5%-10%; efficacy was sustained through week 52. No new safety signals emerged with continued apremilast exposure.</p> <p>ClinicalTrials.gov: NCT02425826</p> <p>J Drugs Dermatol. 2018;17(2):221-228.</p> <p>THIS ARTICLE HAD BEEN MADE AVAILABLE FREE OF CHARGE.</p> <p>PLEASE SCROLL DOWN TO ACCESS THE FULL TEXT OF THIS ARTICLE WITHOUT LOGGING IN.</p> <p>NO PURCHASE NECESSARY.</p> PLEASE CONTACT THE PUBLISHER WITH ANY QUESTIONS.
New Search Next